Nikola N.

Nikola N. has a diverse work experience spanning multiple industries. Nikola is currently working at Quell Therapeutics as the Director of Portfolio Strategy and Business Operations. Prior to this role, they served as the Director of Business Development at the same company. Before joining Quell Therapeutics, Nikola worked as an Investment Executive at CVC Capital Partners. Nikola also gained valuable experience at Boston Consulting Group (BCG) where they served as a Project Leader for five years. During this time, they also had a secondment at Pfizer, where they worked as a Data & Analytics Manager for Rare Diseases. Nikola's earlier experiences include working at the MRC Laboratory of Molecular Biology (LMB) as a Doctoral Degree candidate and at the University of Cambridge as a Stem Cells Researcher. Nikola also worked as a Genomics Researcher at École polytechnique fédérale de Lausanne as part of a scholarship program.

Nikola N. has a PhD from the University of Cambridge, specifically from the MRC Laboratory of Molecular Biology (LMB). Their degree is in Biochemistry and Molecular Biology. Prior to their PhD, they obtained a BSc and MSc in Molecular Biology and Physiology from the University of Belgrade. In terms of secondary education, they attended Britannica International School Belgrade in Serbia. Additionally, they also studied at the Pakistani International School of Cairo in Egypt. Further details about the start and end years for each education institution are not provided.